Prevalence of inflammatory bowel disease (IBD), ulcerative colitis and Crohn's disease has dramatically increased in Asian countries in the last three decades. In this period, many new medical therapies were introduced for the treatment of IBD, such as immunosuppressants, anti-tumor necrosis factor agents, leukocyte apheresis, anti-integrin antibody, and so on, which have contributed to induce remission and to reduce complications in IBD. As for surgical techniques for 
| INTRODUCTION
The prevalence of inflammatory bowel disease (IBD), ulcerative colitis and Crohn's disease has dramatically increased in Asian countries in the last three decades. 1 In this period, many new medical therapies were introduced for the treatment of IBD, such as immunosuppressants, anti-tumor necrosis factor (TNF) agents, leukocyte apheresis, anti-integrin antibody, and so on. 2 Therefore, it can be speculated that the role of surgical treatment for IBD might have changed as compared with that before 2000s.
In this bi-annual review article, recent improvements in IBD treatment will be reviewed. A literature search was conducted on background of each procedure, papers published before 2015 were also reviewed when applicable.
| CROHN' S DISEASE
Crohn's disease has long been recognized as a formidable disease with high recurrence rates even after surgical treatment is attempted. It is well known that anastomotic recurrence occurs endoscopically as early as several months after bowel resection and anastomosis, followed by symptomatic recurrence; reoperation is then often required. 3 Anastomotic recurrence, bowel perforation or abscess formation are not avoidable in most cases 5 or 10 years after the initial operation.
Rates of reoperation are approximately 25% at 5 years, and approximately 40% at 10 years. 4 Patients' quality of life is greatly worsened, which affects patients' education, working, or marriage status.
With the introduction of anti-TNF agents in the early first decade of the 2000s, several studies showed that postoperative use of anti-TNF agents could significantly reduce endoscopic recurrence rates, [5] [6] [7] and clinical recurrence rates in some studies. 5 However, a recent prospective randomized controlled study showed that clinical recurrence rates were not different between the infliximab group and the placebo group (12.9% vs 20% before or at week 76, P = .097; 17.7% vs 25.3% before or at week 104, P = .098). 6 Therefore, the implication of anti-TNF agents in reducing clinical recurrence and surgical recurrence has not yet been determined.
| Surgical treatment for Crohn's disease
A number of retrospective studies reported that a stapled functional end-to-end anastomosis was associated with a lower recurrence rate compared with other types of anastomosis. 8 Simillis et al 9 conducted
a meta-analysis of eight studies reported up to 2005 (two prospective, randomized, controlled trials; one non-randomized, prospective; five non-randomized, retrospective studies), and they concluded that there was no significant difference in perianastomotic recurrence and reoperation needed between conventional end-to-end anastomosis and other anastomotic techniques. This finding was confirmed by a multicenter, randomized, controlled trial reported in 2009. 10 However, the main concern to be considered is that the bowel stump is involved within the anastomosis whether conventional end-to-end anastomosis or other anastomotic techniques are used.
To reduce the risk of anastomotic recurrence of Crohn's disease, Kono developed a novel anastomotic procedure (Kono-S procedure) in 2003. 11 The resection is accomplished by transecting the bowel with a linear cutter so that the mesentery side is located in the center of the stump. Both stumps are sutured to create a supporting column to maintain the diameter and dimension of the anastomosis.
Longitudinal enterotomies are made at the antimesenteric sides of the two segments of intestine. The side-to-side antimesenteric anastomosis is then carried out in a transverse method. 9 By using this method, both stumps are not involved within the anastomosis.
Furthermore, the supporting column is expected to prevent anastomotic distortion as a result of mesenteric longitudinal ulcers.
This technique has gradually been spreading in the leading hospitals of Japan, and was adopted by the University of Chicago, USA from 2010. 12 In 2016, an excellent long-term result was reported by Kono et al. 13 [15] [16] [17] Although the definition of long-term efficacy of EBD has not yet been standardized, several authors reported satisfactory data.
Morar et al 16 observed that after 1, 2, or 5 years, the rate of redilation was approximately 32%, 26%, and 2%, respectively. In their systematic review, Navaneethan et al reported that over a median follow-up period of 15-70 months, 27% of patients required surgical intervention, and 44% required dilation only. They advocated that EBD has a role as a bridge to surgery in the long term. They also claimed that patients' satisfaction with EBD should be considered in clinical practice. 15 Klag et al 14 reported that 83% of patients treated with EBD were satisfied with this procedure, and they would again choose EBD as the first-line treatment, although 34% of these patients eventually underwent surgery after EBD. 
| Endoscopic treatment for fistula and abscess
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Endoscopic fistulotomy
Endoscopic fistulotomy can be indicated for fistulas with a short tract in the distal bowel or perianal area. Dr B. Shen attempted this procedure in several patients with fistulas at the ileocolonic anastomosis for Crohn's disease, or an extrasphincteric perianal fistula/ abscess using needle-knife with proper topical anesthesia if needed. 18 However, the number of patients undergoing this procedure is still limited, and long-term results are awaited.
Endoscopic injection of filling agents
Fibrin glue has been widely used to treat perianal fistula with or without Crohn's disease with various success rates from the early first decade of the 2000s. [19] [20] [21] [22] However, the long-term closure rate of anorectal or perianal fistulas using fibrin glue has been disappoint- 
Endoscopic clipping
There are two types of clipping methods for gastrointestinal diseases. One is the through-the-scope clip (TTSC) method, and the other is the over-the-scope clip (OTSC) method. The former is mainly used for treatment of gastrointestinal bleeding, and anastomotic or suture line leak in non-IBD patients, whereas the latter is designed to close defects along the gastrointestinal tract. 18 A large, multicenter, retrospective study of 188 non-IBD patients (108 fistulas, 48 perforations, 32 leaks) using OTSC showed that the longterm success rate was 60%, and the rates of successful closure of perforations (90%) and leaks (73%) were significantly higher than that of fistulas (43%). 31 However, in patients with Crohn's disease fistulas, there have been few studies in the literature using the OTSC method.
A study from Germany reported that the OTSC method was effective in five out of six patients (83%) with Crohn's disease-associated fistulas; 32 however, a study from Denmark reported that the success rate was only 33% (1/3). 33 The role of the OTSC method in the treatment of Crohn's disease-related fistula remains to be further clarified. 
| Preoperative treatment and postoperative complications
In western countries, ileocecal resection is the most frequent procedure in patients with Crohn's disease. 34 Several risk factors for postoperative complications after ileocecal resection have been reported in previous studies. [35] [36] [37] [38] [39] [40] These were presence of abscess at the time of surgery, corticosteroid therapy, impaired nutritional status, and anti-TNF agents. However, most of the studies included in the meta-analyses were retrospective and from a single institution, and patients' backgrounds were heterogeneous. 
| ULCERATIVE COLITIS
Total proctocolectomy with ileal pouch anal anastomosis (IPAA) is the procedure of choice in the surgical treatment of ulcerative colitis.
Herein, the new concept of surgical techniques, and the short-term and long-term surgical outcomes with special attention to pouch failure will be discussed.
| Surgical techniques
Samples et al 45 Transanal total mesorectal excision (ta-TME) is now a topic in rectal cancer surgery. The same approach has gradually been adopted in proctectomy for ulcerative colitis. 46 | 285
Limitations of this study were the small study population, and one institutional study. Among a total of 2376 patients, 27 non-functional pouches (1.1%) were observed. Anastomotic leakage was selected as a risk factor for pouch failure (odds ratio, 9.1). Cumulative pouch failure rate was 4.2% at 10 years, which was similar to the previous reports from western countries. [51] [52] [53] The authors advocated that the optimal staged surgical operation should be selected according to a patient's condition to avoid anastomotic failure during proctocolectomy. 50 In a recent review by Chang et al, 54 obesity, defined as a BMI of 30 or higher, and pelvic radiation, before or after pouch surgery have been associated with pouch complications, such as anastomotic leak, anastomotic/pouch strictures, and inflammatory pouch complications. It is better to encourage weight loss in obese patients, if applicable. Patients should be informed of the potential risks of radiation exposure to the pouch, and limiting radiation exposure and targeting narrower fields are advisable.
Furthermore, older and elderly patients and women with a history of obstetric complications have increased rates of incontinence after IPAA. Surgeons should pay special attention to preserve sphincter function in these subgroups of ulcerative colitis patients, and a stapled anastomosis should be preferred over a hand-sewn anastomosis. 54 Segal et al 55 conducted a systematic review with meta-analysis on the management of chronic refractory pouchitis, showing that antibiotics (74%; 95% CI: 56%-93%) and biologics (53%; 95% CI: 30%-76%) significantly induced remission in patients with chronic pouchitis; however, steroids, bismuth, elemental diet, tacrolimus and fecal microbiota failed to achieve remission with significance.
| CONCLUSION S
As has been reviewed in this article, the recent improvements of IBD treatment not only contain new medical therapies based on basic science, but also new surgical and endoscopic techniques.
Colorectal surgeons should always keep in touch with these novel ideas and concepts to improve the quality of life of IBD patients.
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